Search
Search Results
##search.searchResults.foundPlural##
-
THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS
2558PDF: 734HTML: 2295 -
OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE
2208PDF: 1037HTML: 1977Characteristic of study group: 196 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2079PDF: 1663HTML: 366 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2429PDF: 780HTML: 1731 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2910PDF: 876HTML: 1593 -
THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies
1496PDF: 528HTML: 266 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2149PDF: 1463HTML: 261 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3868Suppl. Files: 1098PDF: 1060Html: 170 -
A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma
2186PDF: 939HTML: 5057Cover Letter: 166Figure 2: 158Figure 1: 171Figure 3: 192Figure 4: 165Figure Legend: 181Table 1: 184Table 2: 177Table 3: 175 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3220PDF: 930HTML: 2946 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2812PDF: 845HTML: 6516Untitled: 223Untitled: 185Untitled: 199Untitled: 206 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7396PDF: 2411HTML: 1720Table 1.: 204Table 2.: 215Table 3.: 195Table 4.: 195 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3737PDF: 1645HTML: 11555Figures Haase: 193 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3564PDF: 874HTML: 6708 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1023PDF: 1147Suppl. Files: 569HTML: 79 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1169PDF: 748HTML: 1342Figure 1: 185Figure 2: 188 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
1992PDF: 756HTML: 3111 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3851PDF: 1469HTML: 8506 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4268PDF: 1367HTML: 2033 -
TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY
3533PDF: 1063HTML: 872 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1766PDF: 963HTML: 138 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3506PDF: 1547HTML: 75 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1305PDF: 803HTML: 124 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1792PDF: 799HTML: 10226Figures 1,2,3: 171 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1937PDF: 708HTML: 678Table1: patient's characteristics: 153Table 2: profile of each patient: 178







